Year archive

Kadimastem Ltd. — 2022 filings

All 6 regulatory filings released by Kadimastem Ltd. (KDST) in 2022, sourced directly from the official regulator.

6 Filings

2022 Period

2022 filings (6)

Filing	Released	Lang
Rights Offering and Identifying Details for New Security-KADIMASTEM R4 Capital/Financing Update	2022-12-13	Hebrew (modern)
Kadimastem Receives US Patent For Amyotrophic Lateral Sclerosis (ALS) Treatment Regulatory Filings	2022-08-09	English
Kadimastem and Implant Therapeutics, Inc. Sign an Evaluation Agreement Towards the Potential Licensing of Immune Evasive Cells Regulatory Filings	2022-06-08	English
Kadimastem Awarded Patent in Japan for AstroRx For ALS and Drug Screening Regulatory Filings	2022-05-30	English
Kadimastem Expands R&D Program to Include Multiple Sclerosis Regulatory Filings	2022-05-18	English
Kadimastem Receives Grant for a Total Budget of NIS 10 Million ($3.1 million) from the Israeli Innovation Authority Regulatory Filings	2022-03-03	English